Theravance Biopharma Inc (0TB)

Currency in EUR
9.55
0.00(0.00%)
Delayed Data·
0TB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.559.55
52 wk Range
6.8510.20
Key Statistics
Bid/Ask
9.35 / 9.60
Prev. Close
9.55
Open
9.55
Day's Range
9.55-9.55
52 wk Range
6.85-10.2
Volume
-
Average Volume (3m)
1.36K
1-Year Change
1.06%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0TB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Theravance Biopharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Theravance Biopharma Inc Company Profile

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes of medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company’s product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.

Compare 0TB to Peers and Sector

Metrics to compare
0TB
Peers
Sector
Relationship
P/E Ratio
0.0x−1.7x−0.5x
PEG Ratio
0.000.040.00
Price/Book
0.0x3.2x2.6x
Price / LTM Sales
0.0x2.0x3.2x
Upside (Analyst Target)
0.0%128.9%41.2%
Fair Value Upside
Unlock22.6%6.2%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

0TB Income Statement

People Also Watch

20.80
VERA
-0.34%
111.03
CRDO
+2.85%
78.10
ATKR
-0.59%
14.04
DXC
-1.33%
129.46
BPMC
+0.14%

FAQ

What Stock Exchange Does Theravance Biopharma Inc Trade On?

Theravance Biopharma Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Theravance Biopharma Inc?

The stock symbol for Theravance Biopharma Inc is "0TB."

What Is the Theravance Biopharma Inc Market Cap?

As of today, Theravance Biopharma Inc market cap is 474.75M.

What Is Theravance Biopharma Inc's Earnings Per Share (TTM)?

The Theravance Biopharma Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 0TB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Theravance Biopharma Inc Stock Split?

Theravance Biopharma Inc has split 0 times.

What is the current trading status of Theravance Biopharma Inc (0TB)?

As of 29 Jul 2025, Theravance Biopharma Inc (0TB) is trading at a price of 9.55, with a previous close of 9.55. The stock has fluctuated within a day range of 9.55 to 9.55, while its 52-week range spans from 6.85 to 10.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.